ZIYAD ALRABIAH

Dr. ZIYAD ALRABIAH

King Saud Univerisity
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 February 2022 in Healthcare
Verified
Journal Article
Open access
PDF file
ARAijaz Reshi
Aijaz Reshi
Furqan RustamFurqan Rustam
Furqan Rustam
WAWajdi Aljedaani
Wajdi Aljedaani
SSShabana Shafi
Shabana Shafi
AAAbdulaziz Alhossan
Abdulaziz Alhossan
Imran AshrafImran Ashraf
Imran Ashraf
COVID-19 pandemic has caused a global health crisis, resulting in endless efforts to reduce infections, fatalities, and therapies to mitigate its after-effects. Currently, large and fast-paced vaccination campaigns are in the process to reduce COVID-19 infection and fatality risks. Despite recommendations from governments and medical experts, people show conceptions and perceptions regarding vaccination risks and share their views on social media platforms. Such opinions can be analyzed to determine social trends and devise policies to increase vaccination acceptance. In this regard, this study proposes a methodology for analyzing the global perceptions and perspectives towards COVID-19 vaccination using a worldwide Twitter dataset. The study relies on two techniques to analyze the sentiments: natural language processing and machine learning. To evaluate the performance of the different lexicon-based methods, different machine and deep learning models are studied. In addition, for sentiment classification, the proposed ensemble model named long short-term memory-gated recurrent neural network (LSTM-GRNN) is a combination of LSTM, gated recurrent unit, and recurrent neural networks. Results suggest that the TextBlob shows better results as compared to VADER and AFINN. The proposed LSTM-GRNN shows superior performance with a 95% accuracy and outperforms both machine and deep learning models. Performance analysis with state-of-the-art models proves the significance of the LSTM-GRNN for sentiment analysis.

1 May 2020 in Risk Management and Healthcare Policy
Verified
Journal Article
Open access
SBSalmeen D Babelghaith
Salmeen D Babelghaith
WSWajid Syed
Wajid Syed
ZAZIYAD ALRABIAH
ZIYAD ALRABIAH
MOMohammed Abdu M Othiq
Mohammed Abdu M Othiq
SASultan Alghadeer
Sultan Alghadeer
IAIbraheem M Attafi
Ibraheem M Attafi
Objective: This study examined the incidence of drug-related problems (DRPs) in different inpatient departments along with the medical team response to pharmacist’s action in addressing DRPs at Jazan Hospital, Saudi Arabia. Patients and Methods: This retrospective study was conducted among inpatients at Ministry of Health hospital in Jazan, a region in southwestern Saudi Arabia. We collected data for a 2-year period (from 2016 to 2017). For any detected DRP of the ordered medications for dispensing, the inpatient pharmacist is sending report for that particular DRP with recommendation to the medical team which in turn might accept or reject such recommendation. Serious drug–drug interactions, as part of DRP, were assessed by utilizing three different online DDI checkers, including Lexi-Comp, Medscape, and Drugs.com. Results: The most common type of DRP was serious drug–drug interactions (49%). Over the study period, most incidences of DRPs were decreased. Of the DRPs in 2016 and 2017, antibiotics were the most commonly involved (51% and 69.5%) of cases, respectively, followed by proton pump inhibitors (25.3% and 14.1%) and statins (12.9% and 9.4%). Interestingly, of the 241 interventions for DRPs in 2016, 199 (82.5%) were accepted, resulting in a change in drug therapy (p=0.006). In 2017, 90 (70.3%) interventions out of 128 were accepted by the physician and the drug therapy changed (p=0.029). Conclusion: Pharmacist interventions appear to decrease the incidence of DRPs, which emphasize the importance of an optimal pharmaceutical care plan for clinical care settings.

1 January 2022 in INQUIRY: The Journal of Health Care Organization, Provision, and Financing
Verified
Journal Article
Open access
WMWael Mansy
Wael Mansy
SWSyed Wajid
Syed Wajid
AAAbdulrahman Alwhaibi
Abdulrahman Alwhaibi
SASultan M. Alghadeer
Sultan M. Alghadeer
AAAbdulaziz Alhossan
Abdulaziz Alhossan
MNMohamed N-Alarifi
Mohamed N-Alarifi
Introduction: When it comes to non-communicable diseases like diabetes, inadequate knowledge, attitude, and practice are often linked to poor health outcomes. This study aims to assess the patients’ knowledge, attitude, and practice (KAP) of diabetes in the outpatient department of a university teaching hospital in Saudi Arabia. Methodology: In this cross-sectional study, diabetes type 2 patients attending outpatient departments at a university teaching hospital, Riyadh, were assessed regarding their knowledge, attitude, and practice toward diabetes using a validated KAP scale. Descriptive and inferential analysis was done to determine the factors associated with KAP score using SPSS version 26.0 software (SPSS Inc., Chicago, IL, U.S.). Results: Males made up 69.7% of the sample (n = 165), while 56.9% were between the ages of 41 and 75. The level of knowledge and practice had “good” in 37.6%, and 47.9%, respectively, but level of attitude had “positive” in 30.9% of patients. The association between knowledge tier and gender (p0.014) and insurance status (p0.008), respectively, was shown to be significant. However, the attitude tier was only significantly associated with gender ( P = .003). The practice tier also showed a significant age association ( P = .049). As regards, the mean scores for diabetes-related knowledge were higher only among insured participants ( P = .03) than for other participants’ sociodemographic factors. Meanwhile, the mean attitude scores were also higher among males ( P = .006) than for other sociodemographic characteristics. A comparison of the participants’ sociodemographic characteristics found no statistically significant variations in practice scores. Conclusion: Unfortunately, this study found that outpatient diabetes patients had insufficient knowledge, practice, and a negative attitude toward diabetes type 2. This imposes a great burden on healthcare workers and hence the healthcare system to improve patient scores via diabetes education programs or pharmacist-led patient counseling initiatives.

1 May 2019 in Saudi Pharmaceutical Journal
Verified
Journal Article
Open access
ZAZIYAD ALRABIAH
ZIYAD ALRABIAH
AAAbdulaziz Alhossan
Abdulaziz Alhossan
SASultan M. Alghadeer
Sultan M. Alghadeer
WSWajid Syed
Wajid Syed
SBSalmeen D. Babelghaith
Salmeen D. Babelghaith
MNMohamed N-Alarifi
Mohamed N-Alarifi
Although all implemented and ongoing initiatives, drug-drug interactions (DDIs) are still a global problem. Most published studies about DDIs in Saudi Arabia are carried out in hospital settings. In addition, assessing the knowledge of drug interactions in Saudi Arabia is limited. The aim of our study is to evaluate the knowledge of potential common drug-drug interactions among community pharmacists particularly in Saudi Arabia. A crosses-sectional study utilizing a self- administered questionnaire was conducted among community pharmacy in Riyadh city Saudi Arabia. DDIs' knowledge was assessed by 26 drug pairs. Community pharmacists were asked to select the DDIs as "contraindication", "may be used together with monitoring", "no interaction" and "not sure". A total of 283 of community pharmacists completed the survey with response rate of 80.9%. Among the 26 drug pairs only 5 of them were identified correctly by most of the participants. To add more 3 out of the 5 pairs had a cutoff of less than 10% between the correct and wrong answer, meaning there still a majority that couldn't identify the correct answer. All the 26 pairs had a statistically significant difference between the correct and incorrect answer. The results of this study showed that knowledge of community pharmacists about DDIs was inadequate. Community pharmacist should have specific courses in drug interactions to cover the most possible interactions that can be seen in this setting.

SASultan Alghadeer
Sultan Alghadeer
WSWajid Syed
Wajid Syed
AAAbdulaziz Alhossan
Abdulaziz Alhossan
ZAZIYAD ALRABIAH
ZIYAD ALRABIAH
SBSalmeen D. Babelghaith
Salmeen D. Babelghaith
AAAbdulrahman Alwhaibi
Abdulrahman Alwhaibi
This study evaluates the knowledge, attitude of Saudi mothers towards diarrhea in their children and its management at home. Online cross-sectional validated online surveys, targeting Saudi mothers who are living in Saudi Arabia, are used to collect data from the beginning of March to the end of April 2019. Our results show that a total of 1140 mothers (52.1% of them were housewives) participated in the study. Approximately 40.3% of participating mothers believed that childhood diarrhea is a major problem in the Saudi community; however, almost 23% of the participants were unable to identify any critical sign of severe diarrhea, and around 66% falsely stated that diarrhea is caused by teething. Although 62% of our participating mothers knew about oral rehydration therapy (ORS), only 23.5% of them used it for their children. Adequate knowledge about the critical signs, causes, transmission, prevention, and management of childhood diarrhea should be applied in simple language to communicate the health-related information clearly.

1 May 2023 in Pharmacogenomics and Personalized Medicine
Verified
Journal Article
Open access
PDF file
ZAZIYAD ALRABIAH
ZIYAD ALRABIAH
WSWajid Syed
Wajid Syed
SBSalmeen D Babelghaith
Salmeen D Babelghaith
MNMohamed N-Alarifi
Mohamed N-Alarifi
Background and Aims: It is crucial to provide healthcare personnel with the necessary knowledge and understanding of genetic testing and pharmacogenomics. The purpose of this study is to assess the knowledge, attitudes, views, and considerations of Community pharmacists (CPs) about pharmacogenomics and genetics. Methods and Materials: A cross-sectional web-based study was conducted among practicing pharmacists Between January and February of 2022. Participants were recruited through a convenient sampling technique. A total of 23 item questionnaires were used to assess the Knowledge Attitudes, Views, and Considerations toward Pharmacogenomics among pharmacists. Results: The mean age of the CPs were 28.45± 7.29(Std). Among the CPs, 38.4% (98 of 255) of them were correctly identified human chromosomes, and the majority of them 73.3% knew that adverse reactions can be caused by genetic changes in the human body. A total of 194 CPs agreed that certain drugs can be affected by genetic changes in the patient. In this study, one-third (33%) of the CPs were found to have good knowledge, while most (66.3%) of the CPs were found poor knowledge of pharmacogenomics and genetics. Furthermore, the knowledge score is significantly different concerning the qualification of the CPs (p=0.0001). Conclusion: The current findings, demonstrated a majority of the CPs found a lack of knowledge and understanding regarding pharmacogenomics and its perspectives, there is a need to increase awareness among CPs to reduce the knowledge gap of pharmacogenomics and genetics.